Skip to content

Our Team

Asieh Golozar

Director of Clinical Research, OHDSI Center at Northeastern’s Roux Institute

Additional Titles:

  • Professor of the Practice, Bouvé College of Health Sciences 
  • Adjunct Faculty, Department of Epidemiology, Johns Hopkins School of Public Health 
  • Co-lead, OHDSI Oncology Workgroup and OHDSI Steering Committee


Asieh Golozar is a physician-epidemiologist and biostatistician with more than 20 years of experience in health services research, real-world evidence generation, and evaluation of healthcare interventions within government, academia, and industry. She holds a PhD in epidemiology from the Johns Hopkins University School of Public Health and a Master of Health Sciences in biostatistics from JHU, supported by a postdoctoral research fellowship award with the National Cancer Institute’s Division of Cancer Epidemiology and Genetics. She earned her medical degree from the Tehran University of Medical Sciences. 

After receiving her PhD, Golozar joined the faculty at the JHU Department of Epidemiology, where she focused on cancer and diabetes epidemiology, the application of epidemiologic and statistical methods for robust synthesis of evidence from epidemiologic data, and applying evidence-based findings to strengthen public heath infrastructure and policies. In 2017, she moved into industry roles at Bayer AG, AstraZeneca, and Regeneron, where she led lifecycle management and real-world evidence generation activities in oncology, women’s health, and other therapeutic areas. 

As a professor of the practice, Golozar brings a comprehensive knowledge of healthcare systems to Northeastern. She also has the skills in research methodology and statistics required for addressing safety and effectiveness outcomes and risk assessment, and for generating high quality real-world evidence (RWE) from real-world data. She has played leading roles in large-scale private-public partnerships, including the Innovative Medicines Initiative (IMI) Big Data for Better Outcomes project and the IMI PIONEER Prostate Cancer Study-a-thon. 

Since 2018, Golozar has led the OHDSI Oncology Working Group, endeavoring to extend the OMOP common data model to support oncology use cases and advance oncology real-world evidence research. In 2021, Golozar received an OHDSI Titan Award for Clinical Application. In addition to her role at Northeastern, Golozar is an adjunct faculty member at the JHU School of Public Health and vice president of data science at Odysseus Data Services, a leading RWE technology vendor. 

Ask her about:

  • reproducibility at scale
  • oncology
  • cardiovascular and metabolic diseases
  • rare diseases
  • infectious diseases
  • women’s health
  • systematic reviews for RWE
  • how to run an OHDSI study 

We use cookies to improve your experience on our sites. By continuing to use our sites, you agree to our Privacy Statement.